Acceleration of Diabetes Development in CXC Chemokine Receptor 3 (CXCR3)-deficient NOD Mice

Overview

Journal Diabetologia

Specialty Endocrinology

Date 2012 Apr 11

PMID 22487925

Citations 20

Authors

Y Yamada

Y Okubo

A Shimada

Y Oikawa

S Yamada

S Narumi

K Matsushima

H Itoh

Affiliations

Soon will be listed here.

Abstract

Aims/hypothesis: The aim of this study was to understand the role of CXC chemokine receptor 3 (CXCR3), a T-helper 1(Th1) type chemokine receptor, in the pathogenesis of type 1 diabetes.

Methods: We observed the incidence of diabetes in Cxcr3 homozygous knockout mice. We compared the expression pattern of various cytokines and chemokines and the frequency of FOXP3(+) cells in the pancreas and pancreatic lymph nodes from Cxcr3 ( -/- ) NOD mice and wild-type NOD mice. In addition, we observed the migration ability of CXCR3(+)CD4(+) cells to pancreatic islets upon adoptive transfer. Finally, we examined whether Cxcr3 (+) regulatory T cells (Tregs) actually suppressed the onset of diabetes in vivo.

Results: Cxcr3 ( -/- ) NOD mice developed spontaneous diabetes earlier than did wild-type NOD mice. In Cxcr3 ( -/- ) NOD mice, Tregs were more frequent in pancreatic lymph nodes and less frequent in pancreatic islets than in wild-type NOD mice. While transferred CXCR3(-)CD4(+) cells from wild-type NOD mice did not infiltrate pancreatic islets of NOD-severe combined immunodeficiency (SCID) mice, CXCR3(+)CD4(+) cells from the same mice migrated into the recipient islets and contained Forkhead box P3 (FOXP3) upon adoptive transfer. Moreover, CD4(+)CD25(+) cells from wild-type NOD mice suppressed and delayed the onset of diabetes compared with those from Cxcr3 ( -/- ) NOD mice in a cyclophosphamide-induced diabetes model system.

Conclusions/interpretation: The mechanism of accelerated diabetes onset in Cxcr3 ( -/- ) NOD mice was considered to be due to the lack of hybrid Tregs (CXCR3(+)FOXP3(+)CD4(+) cells), which could effectively migrate into and regulate Th1 inflammation in local lesions under Cxcr3 knockout conditions.

Citing Articles

Genome-wide aggregated trans-effects on risk of type 1 diabetes: A test of the "omnigenic" sparse effector hypothesis of complex trait genetics.

Iakovliev A, McGurnaghan S, Hayward C, Colombo M, Lipschutz D, Spiliopoulou A Am J Hum Genet. 2023; 110(6):913-926.

PMID: 37164005 PMC: 10257008. DOI: 10.1016/j.ajhg.2023.04.003.

Pro-inflammatory β cell small extracellular vesicles induce β cell failure through activation of the CXCL10/CXCR3 axis in diabetes.

Javeed N, Her T, Brown M, Vanderboom P, Rakshit K, Egan A Cell Rep. 2021; 36(8):109613.

PMID: 34433033 PMC: 8420815. DOI: 10.1016/j.celrep.2021.109613.

12-Lipoxygenase governs the innate immune pathogenesis of islet inflammation and autoimmune diabetes.

Kulkarni A, Pineros A, Walsh M, Casimiro I, Ibrahim S, Hernandez-Perez M JCI Insight. 2021; 6(14).

PMID: 34128835 PMC: 8410073. DOI: 10.1172/jci.insight.147812.

ICOS Tregs: A Functional Subset of Tregs in Immune Diseases.

Li D, Xiong X Front Immunol. 2020; 11:2104.

PMID: 32983168 PMC: 7485335. DOI: 10.3389/fimmu.2020.02104.

Estrogen regulates sex-specific localization of regulatory T cells in adipose tissue of obese female mice.

Ishikawa A, Wada T, Nishimura S, Ito T, Okekawa A, Onogi Y PLoS One. 2020; 15(4):e0230885.

PMID: 32240221 PMC: 7117686. DOI: 10.1371/journal.pone.0230885.

References

Delovitch T, Singh B . The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity. 1998; 7(6):727-38. DOI: 10.1016/s1074-7613(00)80392-1. View

Hancock W, Lu B, Gao W, Csizmadia V, Faia K, King J . Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J Exp Med. 2000; 192(10):1515-20. PMC: 2193193. DOI: 10.1084/jem.192.10.1515. View

Wilk E, Kalippke K, Buyny S, Schmidt R, Jacobs R . New aspects of NK cell subset identification and inference of NK cells' regulatory capacity by assessing functional and genomic profiles. Immunobiology. 2008; 213(3-4):271-83. DOI: 10.1016/j.imbio.2007.10.012. View

Rabinovitch A . Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation?. Diabetes. 1994; 43(5):613-21. DOI: 10.2337/diab.43.5.613. View

Yamada S, Irie J, Shimada A, Kodama K, Morimoto J, Suzuki R . Assessment of beta cell mass and oxidative peritoneal exudate cells in murine type 1 diabetes using adoptive transfer system. Autoimmunity. 2003; 36(2):63-70. DOI: 10.1080/0891693031000079266. View

Rotondi M, Chiovato L, Romagnani S, Serio M, Romagnani P . Role of chemokines in endocrine autoimmune diseases. Endocr Rev. 2007; 28(5):492-520. DOI: 10.1210/er.2006-0044. View

Shigihara T, Shimada A, Oikawa Y, Yoneyama H, Kanazawa Y, Okubo Y . CXCL10 DNA vaccination prevents spontaneous diabetes through enhanced beta cell proliferation in NOD mice. J Immunol. 2005; 175(12):8401-8. DOI: 10.4049/jimmunol.175.12.8401. View

Christen U, Benke D, Wolfe T, Rodrigo E, Rhode A, Hughes A . Cure of prediabetic mice by viral infections involves lymphocyte recruitment along an IP-10 gradient. J Clin Invest. 2004; 113(1):74-84. PMC: 300760. DOI: 10.1172/JCI17005. View

Turner M, Kane L, Morel P . Dominant role of antigen dose in CD4+Foxp3+ regulatory T cell induction and expansion. J Immunol. 2009; 183(8):4895-903. PMC: 3142864. DOI: 10.4049/jimmunol.0901459. View

10.

Muller M, Carter S, Hofer M, Manders P, Getts D, Getts M . CXCR3 signaling reduces the severity of experimental autoimmune encephalomyelitis by controlling the parenchymal distribution of effector and regulatory T cells in the central nervous system. J Immunol. 2007; 179(5):2774-86. DOI: 10.4049/jimmunol.179.5.2774. View

11.

Frigerio S, Junt T, Lu B, Gerard C, Zumsteg U, Hollander G . Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis. Nat Med. 2002; 8(12):1414-20. DOI: 10.1038/nm1202-792. View

12.

Atkinson M, Maclaren N . The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med. 1994; 331(21):1428-36. DOI: 10.1056/NEJM199411243312107. View

13.

Katz J, Benoist C, Mathis D . T helper cell subsets in insulin-dependent diabetes. Science. 1995; 268(5214):1185-8. DOI: 10.1126/science.7761837. View

14.

Yamamoto T, Yamato E, Tashiro F, Sato T, Noso S, Ikegami H . Development of autoimmune diabetes in glutamic acid decarboxylase 65 (GAD65) knockout NOD mice. Diabetologia. 2003; 47(2):221-4. DOI: 10.1007/s00125-003-1296-0. View

15.

Toyoda H, Formby B . Contribution of T cells to the development of autoimmune diabetes in the NOD mouse model. Bioessays. 1998; 20(9):750-7. DOI: 10.1002/(SICI)1521-1878(199809)20:9<750::AID-BIES8>3.0.CO;2-K. View

16.

Lacotte S, Brun S, Muller S, Dumortier H . CXCR3, inflammation, and autoimmune diseases. Ann N Y Acad Sci. 2009; 1173:310-7. DOI: 10.1111/j.1749-6632.2009.04813.x. View

17.

Rhode A, Pauza M, Barral A, Rodrigo E, Oldstone M, von Herrath M . Islet-specific expression of CXCL10 causes spontaneous islet infiltration and accelerates diabetes development. J Immunol. 2005; 175(6):3516-24. DOI: 10.4049/jimmunol.175.6.3516. View

18.

Nicholas M, Dooley M, Hogan S, Anolik J, Looney J, Sanz I . A novel subset of memory B cells is enriched in autoreactivity and correlates with adverse outcomes in SLE. Clin Immunol. 2007; 126(2):189-201. PMC: 2812414. DOI: 10.1016/j.clim.2007.10.004. View

19.

Shimada A, Morimoto J, Kodama K, Suzuki R, Oikawa Y, Funae O . Elevated serum IP-10 levels observed in type 1 diabetes. Diabetes Care. 2001; 24(3):510-5. DOI: 10.2337/diacare.24.3.510. View

20.

Christen U, McGavern D, Luster A, von Herrath M, Oldstone M . Among CXCR3 chemokines, IFN-gamma-inducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-gamma (CXCL9) imprints a pattern for the subsequent development of autoimmune disease. J Immunol. 2003; 171(12):6838-45. DOI: 10.4049/jimmunol.171.12.6838. View